Development of a Redox-Sensitive Spermine Prodrug for the Potential Treatment of Snyder Robinson Syndrome

Mukund P. Tantak, Vandana Sekhar, Xianzun Tao, R. Grace Zhai, Otto Phanstiel

Open source

DOI
10.1021/acs.jmedchem.1c00419
Published
2021-10-25
Container
Journal of Medicinal Chemistry
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.jmedchem.1c00419,
  title = {Development of a Redox-Sensitive Spermine Prodrug for the Potential Treatment of Snyder Robinson Syndrome},
  author = {Mukund P. Tantak and Vandana Sekhar and Xianzun Tao and R. Grace Zhai and Otto Phanstiel},
  year = {2021},
  journal = {Journal of Medicinal Chemistry},
  doi = {10.1021/acs.jmedchem.1c00419},
  url = {https://doi.org/10.1021/acs.jmedchem.1c00419}
}

RIS

TY  - JOUR
TI  - Development of a Redox-Sensitive Spermine Prodrug for the Potential Treatment of Snyder Robinson Syndrome
AU  - Mukund P. Tantak
AU  - Vandana Sekhar
AU  - Xianzun Tao
AU  - R. Grace Zhai
AU  - Otto Phanstiel
PY  - 2021
JO  - Journal of Medicinal Chemistry
DO  - 10.1021/acs.jmedchem.1c00419
UR  - https://doi.org/10.1021/acs.jmedchem.1c00419
ER  - 

APA

Tantak, M. P., Sekhar, V., Tao, X., Zhai, R. G., & Phanstiel, O. (2021). Development of a Redox-Sensitive Spermine Prodrug for the Potential Treatment of Snyder Robinson Syndrome. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.1c00419

Source records